NAL 0.00% 0.6¢ norwood abbey limited

laser commercialisation update

  1. 22,691 Posts.

    Key points:
    · Asia Pacific distributor’s meeting successful
    · European distributors meeting in late October
    · Progressing towards CE mark for European commercialisation
    · LAD to be exhibited at largest US paediatric meeting November 1-4th

    Norwood Abbey Limited (ASX:NAL) advises that it’s commercial activities for the Laser Assisted Drug
    Delivery (LAD) product are progressing very well.
    A meeting of Asia Pacific medical distributors was held last week with attendees representing Norwood’s
    key Asian countries present. The meeting which was co-hosted by Norwood and its Asia Pacific
    commercialisation partner, MedNet International, included representatives from Korea, Taiwan, China and
    other Asian countries.

    The key objectives of the meeting were to provide Norwood’s partners with detailed sales and marketing
    plans as well as product training to assist them in the introduction of the LAD technology in their markets.
    Over the next few months these distributors will be assessing the market opportunity in their country,
    identifying and accessing key thought-leaders and applying for product registrations where required.

    During October, Norwood will be presenting at a European Distributor Alliance meeting. In addition it is
    planning to exhibit at Medica, Europe’s largest medical products congress to be held in Germany in late

    In support of the commercial strategy for Europe, Norwood is progressing toward receipt of the
    CE Mark for the product, a requirement to promote the product in Europe. The CE Mark is expected in
    early 2004.

    In support of its US Commercial Plan, Norwood will be exhibiting at the American Academy of Pediatrics
    (AAD) meeting in November. This meeting attracts over 10,000 delegates, including specialist children’s
    physicians and nurses. This meeting is a key strategic component of Norwood’s US commercial program.
    Norwood expects to receive strong interest from conference attendees.

    To find out more about the company, visit
    Australia Company Contacts U.S. Investor Contacts
    Bernie Romanin, Lippert Heilshorn & Assoc.
    Director of Marketing Kim Sutton Golodetz
    613-9782 7333 [email protected]
    Bruce Voss
    [email protected]
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.